Work

Resektables MIBC: perioperative Immuntherapie bei fehlender Cisplatin-Eignung zugelassen

Year: 2026

Type: article

Source: Uro-News

DOI: 10.1007/s00092-026-7083-9

Author: Michael Koczorek

Language: German

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7220895696

FWCI:

Cites:

Cited by:

Related to: 10